The DOI matches its Crossref record; the references it cites are not checked yet.
Acromegaly management in the Nordic countries: A Delphi consensus survey
Abstract
Objective: Acromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow‐up exist. However, not all recommendations are strictly evidence‐based. To evaluate consensus on the treatment and follow‐up of patients with acromegaly in the Nordic countries. Methods: A Delphi process was used to map the landscape of acromegaly management in Denmark, Sweden, Norway, Finland, and Iceland. An expert panel developed 37 statements on the treatment and follow‐up of patients with acromegaly. Dedicated endocrinologists (n = 47) from the Nordic countries were invited to rate their extent of agreement with the statements, using a Likert‐type scale (1−7). Consensus was defined as ≥80% of panelists rating their agreement as ≥5 or ≤3 on the Likert‐type scale. Results: Consensus was reached in 41% (15/37) of the statements. Panelists agreed that pituitary surgery remains first line treatment. There was general agreement to recommend first‐generation somatostatin analog (SSA) treatment after failed surgery and to consider repeat surgery. In addition, there was agreement to recommend combination therapy with first‐generation SSA and pegvisomant as second‐ or third‐line treatment. In more than 50% of the statements, consensus was not achieved. Considerable disagreement existed regarding pegvisomant monotherapy, and treatment with pasireotide and dopamine agonists. Conclusion: This consensus exploration study on the management of patients with acromegaly in the Nordic countries revealed a relatively large degree of disagreement among experts, which mirrors the complexity of the disease and the shortage of evidence‐based data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists haven’t been fetched yet
Cited by 4
Research works printed but not linked: 44
- 10.1530/EJE-16-0117 · DOI · Paper page
- 10.1210/er.2018-00115 · DOI · Paper page
- 10.1007/s11102-020-01091-7 · DOI · Paper page
- 10.1007/s11154-020-09588-z · DOI · Paper page
- 10.1007/s12020-018-1590-8 · DOI
- 10.1530/EC-22-0349 · DOI
- 10.1530/EJE-19-0124 · doi:10.1530/eje-19-0124
- 10.1056/NEJM200004203421604 · DOI · Paper page
- 10.1210/jc.2014-2032 · doi:10.1210/jc.2014-2032
- 10.1210/jc.2005-0531 · DOI · Paper page
- 10.1016/S2213-8587(14)70169-X · DOI · Paper page
- 10.3389/fendo.2022.935759 · DOI
- 10.1210/jc.2018-01979 · DOI
- 10.1530/EC-20-0361 · DOI
- 10.1016/j.eprac.2021.12.017 · doi:10.1016/j.eprac.2021.12.017
- 10.1371/journal.pone.0020476 · DOI · Paper page
- 10.1038/s41574-018-0058-5 · DOI · Paper page
- 10.1016/S2213-8587(22)00244-3 · DOI · Paper page
- 10.1007/s11102-023-01360-1 · DOI · Paper page
- 10.1530/EJE-08-0843 · doi:10.1530/eje-08-0843
- 10.1159/000381644 · DOI
- 10.1210/clinem/dgaa444 · DOI
- 10.20945/2359-3997000000195 · DOI
- 10.1210/jc.2008-0315 · doi:10.1210/jc.2008-0315
- 10.1507/endocrj.K10E-203 · doi:10.1507/endocrj.k10e-203
- 10.1530/EJE-09-0908 · DOI
- 10.1177/147323001204000213 · doi:10.1177/147323001204000213
- 10.1530/EJE-14-0249 · doi:10.1530/eje-14-0249
- 10.1007/s11102-014-0602-9 · DOI
- 10.1371/journal.pone.0061523 · doi:10.1371/journal.pone.0061523
- 10.1111/cen.14790 · DOI
- 10.1038/s41598-019-50639-6 · doi:10.1038/s41598-019-50639-6
- 10.1007/s12020-015-0853-x · doi:10.1007/s12020-015-0853-x
- 10.1530/EJE-14-0144 · DOI · Paper page
- 10.1210/jc.2010-0537 · DOI · Paper page
- 10.1530/EC-22-0296 · DOI
- 10.1007/s11102-016-0782-6 · DOI
- 10.1111/cen.14392 · doi:10.1111/cen.14392
- 10.1210/clinem/dgaa405 · doi:10.1210/clinem/dgaa405
- 10.1530/EJE-21-0462 · DOI
- 10.1007/s11102-016-0740-3 · DOI
- 10.1007/s12020-020-02430-1 · doi:10.1007/s12020-020-02430-1
- 10.1210/jc.2014-2700 · DOI · Paper page
- 10.1007/s11102-021-01170-3 · DOI
Metadata
- Authors
- Arlien‐Søborg, M. C., Dal, J., Heck, A., Stochholm, K., Husted, E., Feltoft, C. L., Rasmussen, Å. K., Feldt‐Rasmussen, U., Andreassen, M., Klose, M. C., Nielsen, T. L., Andersen, M. S., Christensen, L. L., Krogh, J., Jarlov, A., Bollerslev, J., Nermoen, I., Oksnes, M., Dahlqvist, P., Olsson, T., Berinder, K., Hoybye, C., Petersson, M., Akerman, A., Wahlberg, J., Ekman, B., Engstrom, B. E., Johannsson, G., Ragnarsson, O., Olsson, D., Sigurjónsdóttir, H. Á., Fougner, S. L., Matikainen, N., Vehkavaara, S., Metso, S., Jaatinen, P., Hämäläinen, P., Rintamäki, R., Yliaska, I., Immonen, H., Mäkimattila, S., Cederberg‐Tamminen, H., Viukari, M., Nevalainen, P., Nuutila, P., Schalin‐Jäntti, C., Burman, P., & Jørgensen, J. O. L.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2024-06-12
- Volume
- 101
- Issue
- 3
- Pages
- 263-273
- ISSN
- 0300-0664
- 1365-2265
- Cited by
- 4
- Language
- en
- Funders
- Pfizer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acromegaly management in the Nordic countries: A Delphi consensus survey. https://app.cochat.ai/papers/10.1111/cen.15095
- The paper
- Arlien‐Søborg, M. C., Dal, J., Heck, A., Stochholm, K., Husted, E., Feltoft, C. L., Rasmussen, Å. K., Feldt‐Rasmussen, U., Andreassen, M., Klose, M. C., Nielsen, T. L., Andersen, M. S., Christensen, L. L., Krogh, J., Jarlov, A., Bollerslev, J., Nermoen, I., Oksnes, M., Dahlqvist, P., . . . Jørgensen, J. O. L. (2024). Acromegaly management in the Nordic countries: A Delphi consensus survey. Clinical Endocrinology. https://doi.org/10.1111/cen.15095
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.